Float:
11.3M
Catalysts / News:
Reports Phase 1 Clinical Data Demonstrating Oral Treatment with Forlumab, a Fully Human Anti-CD3 Monoclonal Antibody
Technical Analysis
Gapping up PreMarket but faded a lot. It continued to climb once market opens.
Original Plan / Strategy
Since it faded so much I didn't expect a PM breakout so once this stock hit the momentum scanner, I waited for a pull back and form a bullflag pattern. Once it does I'll get in at the new high of the candle
Review
I waited for a bull flag pattern that showed up and entered a the breakout of the new high candle. It did pop up but quickly went back down and realized that and sold for a 5 cent profit.
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2020-01-09 09:39:14 | TLSA | buy | $4.200 | long |
2020-01-09 09:39:39 | TLSA | sell | $4.250 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!